With a single click, unlock detailed, AI-assisted insights pulled from hundreds of financial data points instantly.

Abbott (NYSE: ABT) recently reported its Q4 results, with revenues marginally below and earnings meeting the street expectations. The company reported revenue of $10.97 billion and earnings of $1.34 ...

ABT-263 and its structural analogues ABT-199 and ABT-737 inhibit B-cell lymphoma 2 (Bcl-2), BCL2L1 long isoform (Bcl-xL) and BCL2L2 (Bcl-w) proteins and promote cancer cell death. Here, we show that ...

Abbott Laboratories just extended its dividend growth streak with a 7.3% hike in the quarterly dividend per share last month. The company looks set up to deliver double-digit annual adjusted diluted ...

ABT, which had been outperforming the healthcare cohort from the S&P 500 and the S&P 500 itself all through this year, has slumped dramatically following yesterday's Q2 earnings. While Q2 sales beat ...

Step into the showroom at Abt Electronics and you’ll quickly realize this isn’t your typical retailer. The Glenview appliance and electronics store is equipped with a 7,500-gallon saltwater aquarium ...

ABT is trading in the middle of its 52-week range and below its 200-day simple moving average. Price change The price of ABT shares has decreased $0.26 since the market last closed. This is a 0.21% ...